COMPARISON OF INTRAVITREAL INJECTION OF RANIBIZUMAB VERSUS LASER THERAPY FOR ZONE II TREATMENT-REQUIRING RETINOPATHY OF PREMATURITY

PURPOSE: To compare the efficacy of intravitreal injection of ranibizumab (IVR) monotherapy and laser therapy for treatment-requiring retinopathy of prematurity (ROP) in Zone II. METHODS: A prospective, randomized, controlled single-center trial was applied from January 2014 to December 2014; infant...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Guoming, Yang, Mingmin, Zeng, Jian, Vakros, Georgios, Su, Kangjin, Chen, Miaohong, Li, Huilin, Tian, Ruyin, Li, Na, Tang, Song, He, Honghui, Tan, Wenjing, Song, Xiangmei, Zhuang, Runsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Retina 2017
Materias:
Original Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388026/
https://www.ncbi.nlm.nih.gov/pubmed/27529839
http://dx.doi.org/10.1097/IAE.0000000000001241

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388026/
https://www.ncbi.nlm.nih.gov/pubmed/27529839
http://dx.doi.org/10.1097/IAE.0000000000001241

Ejemplares similares